Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers

Table 2 Enablers and barriers for the implementation of telemonitoring in inflammatory bowel disease

	Enablers	Barriers
Technological	Adequate support	Lack of EMR integration
	Sufficient training	System maintenance required to avoid malfunction
	Fast internet connections
	5G network
Organizational	Continuous monitoring	Multidimensional nature: complex comparability between programmes
	Overcome geographic barriers
	Safe assistance during COVID-19 pandemic	Lack of robust data: small studies, short-term follow up periods
	Structured data collection
	Favours experimental studies and epidemiological surveillance	Lack of standardized remote medical practice (Interstate Mecial Licensure compact in the United States)[66]
	Multicentric access to data
		Reimbursement limitations
	Telementoring: professional support and education
Legal		Lack of legal framework[67,68]
		Data security
Acceptability/accessibility	Patient empowerment	Technological knowledge[69-71]; Some demographic factors increase the likelihood of a telematic encounter failure
		High drop-out rate in some clinical trials
	Wide use of smartphones
	Wide use of wearable devices
	Cheap internet plans
Costs	Potential decrease of direct and indirect costs	High initial investment
		Limited cost-effectiveness data